Cargando...
Cardioncological Approach for Trastuzumab Therapy in Breast Cancer Patients With Cardiotoxicity: Impact on Adherence and Clinical Outcome
BACKGROUND: Treatment with Trastuzumab is associated with cardiotoxicity. If Trastuzumab could be administered in a safe manner to patients who develop a reduced left ventricular ejection fraction (EF) of < 50% remains poorly understood. OBJECTIVE: To evaluate the impact of a cardioncological app...
Guardado en:
| Publicado en: | Front Pharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417864/ https://ncbi.nlm.nih.gov/pubmed/32848791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.01190 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|